BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11366686)

  • 21. Lessons from the recently halted microbicide trial in India.
    Krishnan S
    Indian J Med Ethics; 2007; 4(3):121-2. PubMed ID: 18624140
    [No Abstract]   [Full Text] [Related]  

  • 22. Glyminox Biosyn.
    Witherell GW
    Curr Opin Investig Drugs; 2004 Feb; 5(2):222-31. PubMed ID: 15043398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future strategies in microbicide development.
    Rosenberg ZF; Devlin B
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):503-13. PubMed ID: 22406260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The need for a "condoms-only" control group in microbicide trials.
    Jones H; van de Wijgert J; Kelvin E
    Epidemiology; 2003 Jul; 14(4):505; author reply 505-6. PubMed ID: 12843779
    [No Abstract]   [Full Text] [Related]  

  • 25. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-9 contraceptive film and the risk of STDs.
    Netw Res Triangle Park N C; 1997; 17(3):5-7. PubMed ID: 12292395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A summary of preclinical topical microbicide vaginal safety and chlamydial efficacy evaluations in a pigtailed macaque model.
    Patton DL; Cosgrove Sweeney YT; Paul KJ
    Sex Transm Dis; 2008 Oct; 35(10):889-97. PubMed ID: 18607310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific microbicides in the prevention of HIV infection.
    Kelly CG; Shattock RJ
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The acceptability on vaginal microbicides to prevent human immunodeficiency virus/sexually transmitted diseases].
    Han L; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):196-8. PubMed ID: 19565887
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical microbicides: the time has come.
    Dhawan D; Keller M; Klotman ME
    AIDS Read; 2006 Mar; 16(3):144-8, 155-8, 161; discussion 148, 156-7. PubMed ID: 16538955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical vaginal microbicides in HIV/STI prevention.
    Chirenje ZM
    Cent Afr J Med; 2001 Aug; 47(8):209-10. PubMed ID: 12808769
    [No Abstract]   [Full Text] [Related]  

  • 33. Helping patients to reduce their risk of acquiring sexually transmitted disease.
    Braun JF
    J Am Osteopath Assoc; 1992 May; 92(5):646-7. PubMed ID: 1601700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vaginal virucides against HIV].
    Stone AB
    Gynecol Obstet Fertil; 2004; 32(7-8):638-45. PubMed ID: 15450263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
    Olsen ML; Cwiak CA; Koudelka C; Jensen JT
    Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonoxynol-9 fails to prevents STDs, but microbicide research continues.
    Wilkinson D
    Lancet; 2002 Sep; 360(9338):962-3. PubMed ID: 12383661
    [No Abstract]   [Full Text] [Related]  

  • 37. Microbicides and HIV prevention: lessons from the past, looking to the future.
    Morris GC; Lacey CJ
    Curr Opin Infect Dis; 2010 Feb; 23(1):57-63. PubMed ID: 19918175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dual goals of reproductive health.
    Cates W
    Netw Res Triangle Park N C; 1996; 16(3):3 p. PubMed ID: 12293921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.
    Herold BC; Mesquita PM; Madan RP; Keller MJ
    Am J Reprod Immunol; 2011 Mar; 65(3):325-33. PubMed ID: 21143689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies.
    Friend DR; Doncel GF
    Antiviral Res; 2010 Dec; 88 Suppl 1():S47-54. PubMed ID: 21109068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.